>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

March 18, 2014

FDA MedWatch - Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine

Summary:

Merit Medical Systems Custom Procedural Trays Kits Recall Particulates Found in Hospira Lidocaine

March 18, 2014

McKesson Technologies Anesthesia Care: Recall - Patient Case Data May Not Match Patient Data

Summary:

McKesson Technologies Anesthesia Care Recall Patient Case Data May Not Match Patient Data

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Study identifies which bipolar patients will respond to Ketamine therapy for depression, pain

San Francisco — (October 13, 2013) 

Researchers have discovered how to determine which bipolar patients will benefit from Ketamine, a treatment commonly used for depression and pain relief, according to a study presented at the ANESTHESIOLOGY™ 2013 annual meeting.

Two-thirds of patients benefit from Ketamine and using a blood test, researchers can predict which patients will respond favorably.

“Doctors know that very small doses of Ketamine help relieve depression and pain,” said Michael Goldberg, M.D.,  professor and chairman of anesthesiology, and associate dean for education at Cooper Medical School of Rowan University and chief of the Department of Anesthesiology for Cooper University Health Care, Camden, N.J. “But one in three patients do not respond to this treatment. This research will help as we seek ways to provide these patients relief.”

Researchers identified the compound that Ketamine breaks down into, which they named HNK (2S, 6S hydroxynorketamine).  Additionally, researchers discovered the pattern or ‘fingerprint’ in the fatty acids of the blood that indicates which patients will respond to HNK.

In the study, 22 patients with bipolar disorder were given intravenous doses of Ketamine. Blood was collected from each patient. Responders and non-responders were identified using a standardized depression rating scale. A positive response was defined as a 50 percent or greater improvement. Additionally, researchers examined metabolic patterns in blood samples.

Researchers discovered there was a difference in how responders and nonresponders metabolized fatty acids, based on the variability in levels of 18 different metabolites.

“These are significant discoveries which should eventually help in the treatment of patients suffering from depression and chronic pain,” said Irving Wainer, Ph.D., senior investigator with the Intramural Research Program at the National Institute on Aging, Baltimore. “The next step is to look for the genetic or environmental factors that determine whether a person develops the metabolic pattern that responds to the treatment. We hope this leads to the development of customized or individualized treatment for each patient.”

 

THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 50,000 members organized to raise and maintain the standards of the medical practice of anesthesiology. ASA is committed to ensuring that physician anesthesiologists evaluate and supervise the medical care of patients before, during, and after surgery to provide the highest quality and safest care that every patient deserves.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about the role physician anesthesiologists play in ensuring patient safety, visit asahq.org/WhenSecondsCount. Join the ANESTHESIOLOGYTM 2013 social conversation today. Like ASA on Facebook, follow ASALifeline on Twitter and use the hashtag #ANES2013.

###

Contact:

American Society of Anesthesiologists
communications@asahq.org
847-825-5586